Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry

被引：0
|
作者：
Helen E. Jo
Ian Glaspole
Yuben Moodley
Sally Chapman
Samantha Ellis
Nicole Goh
Peter Hopkins
Greg Keir
Annabelle Mahar
Wendy Cooper
Paul Reynolds
E. Haydn Walters
Christopher Zappala
Christopher Grainge
Heather Allan
Sacha Macansh
Tamera J. Corte
机构：
[1] Royal Prince Alfred Hospital,School of Medicine
[2] University of Sydney,School of Medicine
[3] The Alfred Hospital,undefined
[4] Fiona Stanley Hospital,undefined
[5] Royal Adelaide Hospital,undefined
[6] The Austin Hospital,undefined
[7] Prince Charles Hospital,undefined
[8] Princess Alexandria Hospital,undefined
[9] Western Sydney University,undefined
[10] University of Tasmania,undefined
[11] University of Tasmania,undefined
[12] Royal Brisbane and Women’s Hospital,undefined
[13] John Hunter Hospital,undefined
[14] Lung Foundation Australia,undefined
来源：
BMC Pulmonary Medicine | / 18卷
关键词：
Idiopathic pulmonary fibrosis; Interstitial lung disease; Disease severity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Treatment Patterns in Patients with Idiopathic Pulmonary Fibrosis (IPF): Data from the IPF-PRO Registry
    Salisbury, M. L.
    Conoscenti, C. S.
    Culver, D. A.
    Yow, E.
    Neely, M.
    Bender, S.
    Hartmann, N.
    Palmer, S.
    Leonard, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [32] CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) IN THE US: DATA FROM THE IPF-PRO REGISTRY
    Culver, Daniel
    Yow, Eric
    Neely, Megan
    Belperio, John
    Bender, Shaun
    De Andrade, Joao
    Roman, Jesse
    Whelan, Timothy
    Palmer, Scott
    Conoscenti, Craig
    CHEST, 2018, 154 (04) : 397A - 398A
  • [33] MULITPLE PROGRESSION EVENTS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Nathan, S.
    Costabel, U.
    Glaspole, I
    Glassberg, M.
    Lancaster, L.
    Lederer D, J.
    Pereira C, A.
    Trzaskoma, B.
    Limb, S.
    Wells A, U.
    RESPIROLOGY, 2018, 23 : 102 - 102
  • [34] Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry
    Jo, Helen
    Glaspole, Ian
    Grainge, Christopher
    Goh, Nicole
    Hopkins, Peter
    Moodley, Yuben
    Reynolds, Paul
    Chapman, Sally
    Walters, Hayd N.
    Zappala, Christopher
    Allan, Heather
    Keir, Gregory
    Hayen, Andrew
    Cooper, Wendy
    Mahar, Annabelle
    Ellis, Samantha
    Macansh, Sacha
    Corte, Tamera
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [35] Molecular Phenotypes Distinguish Rapid and Slow Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
    Boon, K.
    Bailey, N. W.
    Steele, M. P.
    Groshong, S.
    Yang, J.
    Kervitsky, D.
    Brown, K. K.
    Schwarz, M. I.
    Schwartz, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [36] Vimentin serum biomarkers are differentially related to disease progression in idiopathic pulmonary fibrosis (IPF)
    Simoes, Filipa B.
    Hoyer, Nils
    Prior, Thomas S.
    Jessen, Henrik
    Fredriksen, Peder
    Karsdal, Morten
    Leeming, Diana J.
    Bendstrup, Elisabeth
    Sand, Jannie M. B.
    Shaker, Saher B.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [37] Effect Of Nintedanib On Disease Progression In The Inpulsis® Trials In Patients With Idiopathic Pulmonary Fibrosis (ipf)
    Raghu, G.
    Inoue, Y.
    Behr, J.
    Cottin, V.
    Stowasser, S.
    Stansen, W.
    Maher, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [38] Diagnosis and initial decision-making process in the management of idiopathic pulmonary fibrosis: Analysis from the Australian idiopathic pulmonary fibrosis registry
    Teoh, A.
    Jo, H.
    Tikellis, G.
    Holland, A.
    Glaspole, I
    Moodley, Y.
    Walters, H.
    Grainge, C.
    Hopkins, P.
    Reynolds, P.
    Chapman, S.
    Zappala, C.
    Keir, G.
    Cooper, W.
    Ellis, S.
    Macansh, S.
    Goh, N.
    Corte, T.
    RESPIROLOGY, 2024, 29 : 222 - 222
  • [39] The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
    Zurkova, Monika
    Kolek, Vitezslav
    Lostakova, Vladimira
    Kriegova, Eva
    Sterclova, Martina
    Bartos, Vladimir
    Doubkova, Martina
    Binkova, Ilona
    Svoboda, Michal
    Strenkova, Jana
    Plackova, Martina
    Lacina, Ladislav
    Rihak, Vladimir
    Petrik, Frantisek
    Lisa, Pavlina
    Bittenglova, Radka
    Tyl, Richard
    Ondrejka, Gustav
    Suldova, Hana
    Lnenicka, Jaroslav
    Psikalova, Jana
    Snizek, Tomas
    Homolka, Jiri
    Kralova, Renata
    Kervitzer, Jan
    Vasakova, Martina
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [40] CLINICAL CHARACTERISTICS OF PATIENTS REFERRED TO THE IDIOPATHIC PULMONARY FIBROSIS (IPF) REGISTRY
    SMITH, CM
    PICCHI, MA
    RIES, AL
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A590 - A590
12345